Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?

被引:9
|
作者
Barnes, Katelyn A. [1 ]
Ball, Lauren E. [1 ]
Galvao, Daniel A. [2 ,3 ]
Newton, Robert U. [2 ,3 ]
Chambers, Suzanne K. [1 ,4 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
[2] Edith Cowan Univ, Exercise Med Res Inst, Joondalup, WA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
[4] Univ Technol Sydney, Fac Hlth, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; WEIGHT-LOSS; EXERCISE; DIET; PATTERNS; COMPONENTS; DISEASE; PREVENT; MUSCLE;
D O I
10.1038/s41391-018-0099-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To review the evidence available to support clinical practice guidelines for dietary interventions aimed at mitigating the side effects of androgen deprivation therapy (ADT) in men with prostate cancer, and to identify future research priorities. Methods An analytical model was designed to select and interpret evidence for the effect of dietary interventions on ADT side effects. Key terms identified articles that investigated dietary interventions to mitigate ADT side effects among men treated for prostate cancer. Medline, Embase, Proquest, CINAHL, Cochrane databases, and PubMed were searched from inception through June, 2018. Clinical trial registries were also searched for up-to-date study protocols. Articles were not restricted on design. Methodological quality was assessed using the mixed methods appraisal tool. Results Sixteen articles met inclusion criteria, each with distinct dietary interventions. Twelve studies used interventions that combined diet with physical activity and/or medication and/or counselling. Four articles examined the effect of diet alone on ADT side effects. Of those, three articles measured changes to participants' dietary intake and influence on ADT side effects. One article showed daily caffeinated beverages improved cancer-related fatigue. Two articles showed no impact of isoflavone supplementation on hot flushes, quality of life, body mass index, or blood lipids. Dietary intake and compliance was poorly reported across all studies limiting knowledge of acceptability and feasibility for dietary interventions. Information on the nutrition care practices and views of clinicians treating men for prostate cancer is limited. No articles measured the impact of diet on long-term ADT side effects. Methodological quality of included papers ranged from weak to strong. Conclusions Current evidence for dietary interventions to mitigate ADT side effects is limited. Further investigations are warranted to explore the impact of changes in dietary intake on ADT side effects before practice guidelines can be considered.
引用
收藏
页码:221 / 234
页数:14
相关论文
共 50 条
  • [1] Nutrition care guidelines for men with prostate cancer undergoing Androgen Deprivation Therapy: Do we have enough evidence?
    Barnes, Katelyn A.
    Ball, Lauren E.
    Newton, Robert U.
    Galvao, Daniel A.
    Chambers, Suzanne K.
    [J]. BJU INTERNATIONAL, 2018, 122 : 16 - 16
  • [2] Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?
    Katelyn A. Barnes
    Lauren E. Ball
    Daniel A. Galvão
    Robert U. Newton
    Suzanne K. Chambers
    [J]. Prostate Cancer and Prostatic Diseases, 2019, 22 : 221 - 234
  • [3] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [4] Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer
    Hamilton, K.
    Chambers, S. K.
    Legg, M.
    Oliffe, J. L.
    Cormie, P.
    [J]. SUPPORTIVE CARE IN CANCER, 2015, 23 (01) : 133 - 142
  • [5] Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    M Braga-Basaria
    D C Muller
    M A Carducci
    A S Dobs
    S Basaria
    [J]. International Journal of Impotence Research, 2006, 18 : 494 - 498
  • [6] Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer
    Gild, Philipp
    Cole, Alexander P.
    Krasnova, Anna
    Dickerman, Barbra A.
    von Landenberg, Nicolas
    Sun, Maxine
    Mucci, Lorelei A.
    Lipsitz, Stuart R.
    Chun, Felix K. -H.
    Nguyen, Paul L.
    Kibel, Adam S.
    Choueiri, Toni K.
    Basaria, Shehzad
    Quoc-Dien Trinh
    [J]. JOURNAL OF UROLOGY, 2018, 200 (03): : 573 - 580
  • [7] Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
    Braga-Basaria, M.
    Muller, D. C.
    Carducci, M. A.
    Dobs, A. S.
    Basaria, S.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (05) : 494 - 498
  • [8] Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer
    K. Hamilton
    S. K. Chambers
    M. Legg
    J. L. Oliffe
    P. Cormie
    [J]. Supportive Care in Cancer, 2015, 23 : 133 - 142
  • [9] Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy
    Cheung, Ada S.
    de Rooy, Casey
    Hoermann, Rudolf
    Joon, Daryl Lim
    Zajac, Jeffrey D.
    Grossmann, Mathis
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 86 (03) : 388 - 394
  • [10] Sexual Bother in Men with Advanced Prostate Cancer Undergoing Androgen Deprivation Therapy
    Benedict, Catherine
    Traeger, Lara
    Dahn, Jason R.
    Antoni, Michael
    Zhou, Eric S.
    Bustillo, Natalie
    Penedo, Frank J.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2014, 11 (10): : 2571 - 2580